Adult stem cells and their trans-differentiation potential—perspectives and therapeutic applications

被引：0

作者：

Sabine Hombach-Klonisch

Soumya Panigrahi

Iran Rashedi

Anja Seifert

Esteban Alberti

Paola Pocar

Maciej Kurpisz

Klaus Schulze-Osthoff

Andrzej Mackiewicz

Marek Los

机构：

[1] University of Manitoba,Department of Human Anatomy and Cell Science

[2] University of Manitoba,Department of Physiology

[3] University of Manitoba,Manitoba Institute of Cell Biology, CancerCare Manitoba

[4] University of Manitoba,Department of Biochemistry and Medical Genetics

[5] CIREN,Department of Neurobiology, International Center of Neurological Restoration

[6] University of Milan,Department of Animal Science, Faculty of Veterinary Medicine

[7] Polish Academy of Science,Institute of Human Genetics

[8] University of Duesseldorf,Institute of Molecular Medicine

[9] Poznan University of Medical Sciences,Department of Cancer Immunology

[10] and Great-Poland Cancer Center,undefined

[11] BioApplications Enterprises,undefined

来源：

Journal of Molecular Medicine | 2008年 / 86卷

关键词：

Autoimmune disease; G-CSF; Graft vs. host reaction; Stem/progenitor cell; Trans-differentiation;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Stem cells are self-renewing multipotent progenitors with the broadest developmental potential in a given tissue at a given time. Normal stem cells in the adult organism are responsible for renewal and repair of aged or damaged tissue. Adult stem cells are present in virtually all tissues and during most stages of development. In this review, we introduce the reader to the basic information about the field. We describe selected stem cell isolation techniques and stem cell markers for various stem cell populations. These include makers for endothelial progenitor cells (CD146/MCAM/MUC18/S-endo-1, CD34, CD133/prominin, Tie-2, Flk1/KD/VEGFR2), hematopoietic stem cells (CD34, CD117/c-Kit, Sca1), mesenchymal stem cells (CD146/MCAM/MUC18/S-endo-1, STRO-1, Thy-1), neural stem cells (CD133/prominin, nestin, NCAM), mammary stem cells (CD24, CD29, Sca1), and intestinal stem cells (NCAM, CD34, Thy-1, CD117/c-Kit, Flt-3). Separate section provides a concise summary of recent clinical trials involving stem cells directed towards improvement of a damaged myocardium. In the last part of the review, we reflect on the field and on future developments.

引用

页码：1301 / 1314

页数：13

共 884 条

[1]

Filip S(2004)Issues in stem cell plasticity J Cell Mol Med 8 572-577

[2]

English D(2008)Cancer stem cells as targets for cancer therapy: selected cancers as examples Arch Immunol Ther Exp 56 165-180

[3]

Mokry J(2005)Postnatal stem cell survival: does the niche, a rare harbor where to resist the ebb tide of differentiation, also provide lineage-specific instructions? J Leukoc Biol 78 836-844

[4]

Hombach-Klonisch S(2002)The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors Blood 99 507-512

[5]

Paranjothy T(2006)The function of breast cancer resistance protein in epithelial barriers, stem cells and milk secretion of drugs and xenotoxins Trends Pharmacol Sci 27 10-16

[6]

Wiechec E(1997)The intestinal epithelial stem cell: the mucosal governor Int J Exp Pathol 78 219-243

[7]

Pocar P(2007)Stem cells: a revolution in therapeutics—recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies Clin Pharmacol Ther 82 252-264

[8]

Mustafa T(2007)Isolation of bone marrow-derived stem cells using density-gradient separation Exp Hematol 35 335-341

[9]

Seifert A(2006)Sterile and disposable fluidic subsystem suitable for clinical high speed fluorescence-activated cell sorting Cytometry B Clin Cytom 70 344-354

[10]

Zahl C(1979)Future directions for flow cytometry J Histochem Cytochem 27 1649-1654

← 1 2 3 4 5 6 7 8 9 10 →